Rand Corp.
This article was originally published in The Gray Sheet
Executive Summary
"Managed Care and the Evaluation and Adoption of Emerging Technology" study is scheduled for release March 21. The study is intended to provide tips on how medical device manufacturers prepare for device evaluation and coverage decisions by managed care organizations. Sponsors of the study include the California Goldstrike Partnership of the State of California's Trade and Commerce Agency, the Economic Development Administration of the U.S. Department of Commerce, and the Health Industry Manufacturers Association (1"The Gray Sheet" May 24, 1999, In Brief)
You may also be interested in...
HIMA technology adoption study
Rand Health is selected by the Health Industry Manufacturers Association to conduct a study on the adoption of new medical technology in managed care settings. Expected to be complete by late fall, the study will identify how managed care organizations currently review and pay for technology, and how device firms prepare for this process. The study "may reveal voluntary 'best practices' for introducing emerging technologies into the managed care environment," HIMA says
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.